Search Keyword:


Search option:


IID00733
UniprotQ96S59
ProteinRan-binding protein 9
GeneRANBP9
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
729
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 108-350 Hetero tetramer : IID50332Complex
 Evidence X-RAY 5jiu A Reference
       Region 5jiu A 108-140 disorder
       Region 5jiu A 141-349 order
       Region 5jiu A 350-350 disorder
 Evidence X-RAY 5jiu B Reference
       Region 5jiu B 108-140 disorder
       Region 5jiu B 141-349 order
       Region 5jiu B 350-350 disorder
Seq 108-350 Monomer :
 Evidence X-RAY 5ji7 A Reference
       Region 5ji7 A 108-146 disorder
       Region 5ji7 A 147-345 order
       Region 5ji7 A 346-350 disorder
 Evidence X-RAY 5ji9 A Reference
       Region 5ji9 A 108-140 disorder
       Region 5ji9 A 141-345 order
       Region 5ji9 A 346-350 disorder
Seqphosphorylation
    477-477 Phosphoserine
    487-487 Phosphoserine
Seqacetylation
    405-405 N6-acetyllysine
 
Prediction
NeProc
Disorder 1-161,464-611
Order 162-463,612-729
ProS 92-99,142-161,464-474,495-515,541-562,568-611
AlphaFold
Disorder 1-4,9-140,464-608,729-729
Order 5-8,141-463,609-728
Pfam Hmmer
PF00622 212-333 2.1e-37
PF08513 367-393 0.00017
SEG 2-126 ,473-489
Function
Function in SwissProt
May act as scaffolding protein, and as adapter protein to couple membrane receptors to intracellular signaling pathways (Probable). Acts as a mediator of cell spreading and actin cytoskeleton rearrangement (PubMed:18710924). Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1 (PubMed:29911972). May be involved in signaling of ITGB2/LFA-1 and other integrins (PubMed:14722085). Enhances HGF-MET signaling by recruiting Sos and activating the Ras pathway (PubMed:12147692). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but not affect estrogen-induced transactivation (PubMed:12361945, PubMed:18222118). Stabilizes TP73 isoform Alpha, probably by inhibiting its ubiquitination, and increases its proapoptotic activity (PubMed:15558019). Inhibits the kinase activity of DYRK1A and DYRK1B. Inhibits FMR1 binding to RNA.